全文获取类型
收费全文 | 10323篇 |
免费 | 1662篇 |
国内免费 | 322篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 261篇 |
妇产科学 | 196篇 |
基础医学 | 3276篇 |
口腔科学 | 210篇 |
临床医学 | 1137篇 |
内科学 | 1531篇 |
皮肤病学 | 187篇 |
神经病学 | 554篇 |
特种医学 | 388篇 |
外国民族医学 | 2篇 |
外科学 | 482篇 |
综合类 | 957篇 |
现状与发展 | 2篇 |
预防医学 | 824篇 |
眼科学 | 189篇 |
药学 | 467篇 |
5篇 | |
中国医学 | 352篇 |
肿瘤学 | 1237篇 |
出版年
2024年 | 26篇 |
2023年 | 571篇 |
2022年 | 672篇 |
2021年 | 1154篇 |
2020年 | 1025篇 |
2019年 | 910篇 |
2018年 | 788篇 |
2017年 | 717篇 |
2016年 | 661篇 |
2015年 | 646篇 |
2014年 | 781篇 |
2013年 | 688篇 |
2012年 | 425篇 |
2011年 | 386篇 |
2010年 | 244篇 |
2009年 | 249篇 |
2008年 | 233篇 |
2007年 | 224篇 |
2006年 | 225篇 |
2005年 | 194篇 |
2004年 | 174篇 |
2003年 | 146篇 |
2002年 | 153篇 |
2001年 | 151篇 |
2000年 | 118篇 |
1999年 | 104篇 |
1998年 | 72篇 |
1997年 | 101篇 |
1996年 | 60篇 |
1995年 | 64篇 |
1994年 | 72篇 |
1993年 | 38篇 |
1992年 | 41篇 |
1991年 | 21篇 |
1990年 | 24篇 |
1989年 | 21篇 |
1988年 | 23篇 |
1987年 | 10篇 |
1986年 | 10篇 |
1985年 | 19篇 |
1984年 | 13篇 |
1983年 | 8篇 |
1982年 | 12篇 |
1981年 | 11篇 |
1980年 | 8篇 |
1979年 | 5篇 |
1977年 | 3篇 |
1975年 | 2篇 |
1973年 | 1篇 |
1970年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 17 毫秒
91.
M. Ruiz‐Estvez F. J. Ruiz‐Ruano J. Cabrero M. Bakkali F. Perfectti M. D. Lpez‐Len J. P. M. Camacho 《Insect molecular biology》2015,24(3):319-330
We analyse intragenomic variation of the ITS2 internal transcribed spacer of ribosomal DNA (rDNA) in the grasshopper Eyprepocnemis plorans, by means of tagged PCR 454 amplicon sequencing performed on both genomic DNA (gDNA) and RNA‐derived complementary DNA (cDNA), using part of the ITS2 flanking coding regions (5.8S and 28S rDNA) as an internal control for sequencing errors. Six different ITS2 haplotypes (i.e. variants for at least one nucleotide in the complete ITS2 sequence) were found in a single population, one of them (Hap4) being specific to a supernumerary (B) chromosome. The analysis of both gDNA and cDNA from the same individuals provided an estimate of the expression efficiency of the different haplotypes. We found random expression (i.e. about similar recovery in gDNA and cDNA) for three haplotypes (Hap1, Hap2 and Hap5), but significant underexpression for three others (Hap3, Hap4 and Hap6). Hap4 was the most extremely underexpressed and, remarkably, it showed the lowest sequence conservation for the flanking 5.8‐28S coding regions in the gDNA reads but the highest conservation (100%) in the cDNA ones, suggesting the preferential expression of mutation‐free rDNA units carrying this ITS2 haplotype. These results indicate that the ITS2 region of rDNA is far from complete homogenization in this species, and that the different rDNA units are not expressed at random, with some of them being severely downregulated. 相似文献
92.
Geneticists have, for years, understood the nature of genome‐wide association studies using common genomic variants. Recently, however, focus has shifted to the analysis of rare variants. This presents potential problems for researchers, as rare variants do not always behave in the same way common variants do, sometimes rendering decades of solid intuition moot. In this paper, we present examples of the differences between common and rare variants. We show why one must be significantly more careful about the origin of rare variants, and how failing to do so can lead to highly inflated type I error. We then explain how to best avoid such concerns with careful understanding and study design. Additionally, we demonstrate that a seemingly low error rate in next‐generation sequencing can dramatically impact the false‐positive rate for rare variants. This is due to the fact that rare variants are, by definition, seen infrequently, making it hard to distinguish between errors and real variants. Compounding this problem is the fact that the proportion of errors is likely to get worse, not better, with increasing sample size. One cannot simply scale their way up in order to solve this problem. Understanding these potential pitfalls is a key step in successfully identifying true associations between rare variants and diseases. 相似文献
93.
94.
C. Banella M. Ginevrino G. Catalano E. Fabiani G. Falconi M. Divona P. Curzi P. Panetta M.T. Voso N.I. Noguera 《Hematology/oncology and stem cell therapy》2021,14(2):163-168
FGFR–TACC, found in different tumor types, is characterized by the fusion of a member of fibroblast grown factor receptor (FGFR) tyrosine kinase (TK) family to a member of the transforming acidic coiled-coil (TACC) proteins. Because chromosome numerical alterations, hallmarks of FGFR–TACC fusions are present in many hematological disorders and there are no data on the prevalence, we studied a series of patients with acute myeloid leukemia and myelodysplastic syndrome who presented numerical alterations using cytogenetic traditional analysis. None of the analyzed samples showed FGFR3–TACC3 gene fusion, so screening for this mutation at diagnosis is not recommended. 相似文献
95.
M.-D.-M. Amador F. Muratet E. Teyssou S. Boillée S. Millecamps 《Revue neurologique》2021,177(5):524-535
Due to novel gene therapy opportunities, genetic screening is no longer restricted to familial cases of ALS (FALS) cases but also aplies to the sporadic populations (SALS). Screening of four main genes (C9orf72, SOD1, TARDBP and FUS) identified the causes in 15% of Amyotrophic Lateral Sclerosis (ALS) patients (two third of the familial cases and 8% of the sporadic ones) but their respective contribution to ALS phenotype varies according the age of disease onset. The genetic overlap between ALS and other diseases is expanding and includes frontotemporal dementia, Paget's Disease of Bone, myopathy for adult cases, HSP and CMT for young cases highlighing the importance of retrieving the exhaustive familial history for each indivdual with ALS. Incomplete disease penetrance, diversity of the possible phenotypes, as well as the lack of confidence concerning the pathogenicity of most identified variants and/or possible oligogenic inheritance are burdens of ALS genetic counseling to be delivered to patients and at risk individuals. The multitude of rare ALS genetic causes identifed seems to converge to similar cellular pathways leading to inapropriate response to stress emphacising new potential therapeutic options for the disease. 相似文献
96.
Introduction:Subchromosomal deletions and duplications could currently be detected by noninvasive preliminary screening (NIPS). However, NIPS is a screening test that requires further diagnosis. Here we report a fetus with an autosomal abnormality revealed by NIPS and conventional karyotype combined with copy number variations sequencing (CNV-seq) confirmed the fetus with an unbalanced translocation.Patient concern:This was the fourth pregnancy of a 30-year-old woman who underwent 2 spontaneous abortions and gave birth to a child with a normal phenotype. The woman and her husband were healthy and nonconsanguineous. NIPS indicated a repeat of about 19-Mb fragment at the region of 16q22.1-q22.4 at 17-week gestation.Diagnoses:The combination of traditional karyotype and CNV-seq could better locate the abnormal chromosomal region and further identify the source of fetal chromosomal abnormalities. Simultaneously, we evaluated the fetal morphology by ultrasound examination. The karyotype of the fetus was 46,XX,der(7)t(7;16)(p22;q23) and CNV-seq results showed an approximately 20.96-Mb duplication in 16q22.1-q24.3 (69200001-90160000) and an approximately 3.86-Mb deletion in 7p22.3-p22.2 (40001-3900000). Prenatal ultrasound revealed the fetal micrognathia. The paternal karyotype was 46,XY, t (7;16) (p22;q23), while the maternal was normal. The fetus inherited an abnormal chromosome 7 from its father.Interventions:No treatment for the fetus.Outcomes:Pregnancy was terminated.Conclusions:To our knowledge, the occurrence of de novo partial trisomy 16q (16q22.1-qter) and partial monosomy 7p (7p22.2-pter) has not previously been reported up to now. Here, we present the perinatal findings of such a case and a review of the literatures. CNV-seq combined with karyotype is a useful tool for chromosomal abnormalities indicated by NIPS. 相似文献
97.
98.
《The Journal for Nurse Practitioners》2021,17(1):32-36
Despite health care reform, our nation continues to struggle containing health care costs while meeting the needs of persons with behavioral health disorders and comorbid chronic care conditions. The purpose of this article is to propose that dually certified primary care and psychiatric mental health nurse practitioners may be the disruptive innovation that becomes the solution for improving the coordination and care for high-need patients while containing costs. The concepts of disruptive innovation, integrated care, and whole person care are discussed followed by an introduction to the innovative primary care and psychiatric mental health nurse practitioner’s role and its potential for health care system disruption. Finally, a call to nursing is proffered to seize current opportunities to meet the Triple Aim challenge by providing whole person care that is high-quality, cost-effective, and satisfactory to patients because it is truly patient centered and meets their needs. 相似文献
99.
通过为1例晚期肿瘤患者提供由住院到居家无缝隙对接的全程照护,以远程医疗为媒介,为居家患者提供症状控制指导、舒适护理指导、心理灵性的支持以及最后的哀伤辅导。真正做到全人、全家、全程、全团队的“四全照顾”。最终做到患者善终、家人善别、生者善生。 相似文献
100.